old eternal affairs truth media header banner

mRNA Vaccinated Animal Meat May Very Soon Be a Reality in Our Food Supply

us-meat-supply-bostonherald-com-2023-truth

Meat From Animals Vaccinated With mRNA Vaccines May Soon Make Its Way Into The US Food Supply

mRNA Vaccinated Animal Meat May Very Soon Be a Reality in Our Food Supply

Activist Post reports:

us-meat-supply-bostonherald-com-2023-truth
IMAGE SCREENSHOT / bostonherald.com

Trump / Vance 2024 - White

GET YOUR FLAG HERE TODAY


Shrimp have become the latest addition to a growing list of food sources targeted by mRNA gene therapy technology. An Israeli company seeking to bring mRNA vaccines to shrimp farming has raised $8.25 million  from a group of venture capitalists to promote and improve animal  health in marine species through its orally administered RNA-particle  platform.

ViAqua, a biotechnology company, created an RNA-based vaccine product that uses ribonucleic acid interference (RNAi) to manipulate gene expression in shrimp. RNAi  is a biological process where RNA molecules are used to inhibit gene  expression or translation by neutralizing targeted mRNA molecules.

[fyrebox oid=”pNvEGJVD0″ gid=”0B4zp8GOR”]

The vaccine comes in the form of a coated feed supplement designed to  enhance resistance to white spot syndrome virus (WSSV)—a viral  infection that causes an annual loss of about $3 billion and a 15 percent reduction in  global shrimp production. ViAqua suggests RNA molecules can inhibit the  expression of genes that cause disease with every meal containing its  coated product.

According to a 2022 proof-of-concept study, the nanovaccine was roughly 80 percent effective in a lethal WSSV challenge model  and exhibited excellent in vivo safety profiles. Yet the risks of  altering gene expression in shrimp and the effects of consuming  vaccinated shrimp are unknown.

“Oral delivery is the holy grail of aquaculture health development  due to both the impossibility of vaccinating individual shrimp and its  ability to substantially bring down the operational costs of disease  management while improving outcomes,” said Shai Ufaz, CEO of ViAqua in a  press release. “We are excited to bring this technology to market to  address the need for affordable disease solutions in aquaculture.”

ViAqua plans to begin production in India in 2024 and believes its  technology has numerous applications in aquaculture and beyond,  according to their press release.

READ THIS  Switzerland's New Portable Suicide 'Pod' Set to Claim Its First Life 'Soon'

mRNA Vaccines Are Already Used in Pigs

[fyrebox oid=”pNvEGJVD0″ gid=”0B4zp8GOR”]




Truth Premium
CLICK HERE -->I Want Truth Premium


Trump Terminator BobbleHead Doll - 2024 - Take America Back


5 1 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments

Buy Me A Coffee

Please use the buttons to TWEET & SHARE this valuable content ... then leave your thoughts & feelings in the COMMENT SECTION ... finally If you haven't joined TRUTH PREMIUM, what are you waiting for?